Left ventricular remodelling in patients with reversible ischemic dysfunction before and after myocardial revascularization
Abstract
Aim. To study the dynamics of left ventricular (LV) remodelling in patients with myocardial infarction (MI) and reversible ischemic dysfunction, before and after myocardial revascularization.
Material and methods. The study included 69 patients after MI. All participants underwent two-dimensional echocardiography (EchoCG), within 24 hours after hospital admission and one month after revascularization. After three-four days of treatment and clinical stabilization, the patients underwent stress EchoCG with dobutamine, to assess myocardial viability.
Results. Complete or partial recovery of all asynergic myocardial segments was observed in 22 (Group I) and 19 (Group II) patients, respectively, while in 28 (Group III), LV aneurysm was detected. In most patients from each group, transluminal balloon angioplasty (TLBAP) with stent implantation was performed. The proportion of conservatively treated patients was maximal in Group III. Despite revascularization, in coronary patients with impaired myocardial viability (Group III), the increase in ejection fraction and reduction in end-systolic volume was significantly lower than in patients with viable myocardium. Sphericity index, relative wall thickness index, and myocardial stress parameters were increased in each group, although this increase was non-significant in Group III. After revascularization, a significant reduction in end-systolic volume, and a tendency towards enddiastolic LV volume reduction were observed in each group, being maximal in Group I.
Conclusion. In MI patients with viable myocardium in dyskineticLV zones, revascularization surgery should be considered.
About the Authors
Kh. A. MamatkulovUzbekistan
Tashkent
A. L. Alyavi
Uzbekistan
Tashkent
M. L. Kenzhaev
Uzbekistan
Tashkent
D. A. Alimov
Uzbekistan
Tashkent
S. R. Kenzhaev
Uzbekistan
Tashkent
References
1. Беленков Ю.Н., Мареев В.Ю., Орлова Я.А. и др. Магнитнорезонансная томография в оценке ремоделирования левого желудочка у больных с сердечной недостаточностью. Кардиология 1996; 36(4): 15-22.
2. Бокерия Л.А., Бузиашвили Ю.И. Чреспищеводная эхокардиография в коронарной хирургии. Издательство НЦССХ им. А.Н. Бакулева Москва 1999; 120 с.
3. Braumgarther H, Porenta G, Lan YK, et al. Assessment of myocardial viability by dobutamine echocardiography, PET and thallium-201 SPECT: correlation with histopathology in explanated hearts. JACC 1998; 32: 1701-8.
4. Geraci E, Franzosi MG, Santoro E, et. al. Ten-year-follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction. Circulation 1998; 98: 2659-65.
5. Jugdutt Bodh I. Apoptosis after reperfused myocardial infarction: Role of angiotensin II.
6. Exper clin cardiol 2004; 9(4): 219-28.
7. La Carina G, Rahimtoola SH, Visioli O, et al. Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly in combination, for diagnosis of hibernating myocardium. Eur Heart J 2000; 21(16): 1358-67.
8. Marchese A, Galiuto L, Cavallari D, et al. The protective effect of coronary collateral circulation on myocardial viability: a case of acute coronary occlusion. Cardiologia (Rome, Italy) 1994; 39(5): 359-62.
9. Morgan JP, Erny RE, Allen PD, et al. Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure. Circulation 1990; 81 (suppl III): 111-21-32.
10. Panza JA, Laurienzo JM, Curiel RV, et al. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. JACC 1994; 24(5): 1260-7.
11. Popovic MD, Bojic M, Aleksandar D, et al. Detection of significant residual stenosis of the infarct-related artery after thrombolysis by high-dose dipyridamole echocardiography test: Is it detected often enough? Сlin Cardiol 1997; 20(6): 569-72.
Review
For citations:
Mamatkulov Kh.A., Alyavi A.L., Kenzhaev M.L., Alimov D.A., Kenzhaev S.R. Left ventricular remodelling in patients with reversible ischemic dysfunction before and after myocardial revascularization. Cardiovascular Therapy and Prevention. 2011;10(7):28-32. (In Russ.)